Monte Rosa Therapeutics shares owned by Bank of America Corporation
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by Bank of America Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $389k | 73k | 5.30 |
| 2024-06-30 | $256k | 69k | 3.74 |
| 2024-03-31 | $438k | 62k | 7.05 |
| 2023-12-31 | $456k | 81k | 5.65 |
| 2023-09-30 | $391k | 82k | 4.79 |
| 2023-06-30 | $576k | 84k | 6.85 |
| 2023-03-31 | $389k | 50k | 7.79 |
| 2022-12-31 | $602k | 79k | 7.61 |
| 2022-06-30 | $1.2M | 126k | 9.67 |
| 2021-12-31 | $1.3M | 66k | 20.51 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation